| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
5,560,000,000 |
| Market
Cap: |
160.24(B) |
| Last
Volume: |
38,365,664 |
Avg
Vol: |
30,558,062 |
| 52
Week Range: |
$25.26 - $40.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.5 |
| Insider 3/6 Months : 7.1 |
|
| Guru Rank Number : 710 |
| Guru Rank Value : 1.7 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
3,000 |
3,000 |
5,000 |
| Total Buy Value |
$0 |
$79,401 |
$79,401 |
$156,406 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
18,130 |
| Total Sell Value |
$0 |
$0 |
$0 |
$826,281 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rogers Dawn |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,943 |
49,992 |
|
- |
|
| Rogers Dawn |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$621,942 |
D/D |
19,297 |
45,049 |
|
- |
|
| Read Ian C |
Executive Chairman |
• • – |
2019-02-27 |
4 |
D |
$42.93 |
$10,474,748 |
D/D |
(243,996) |
1,690,068 |
|
- |
|
| Read Ian C |
Executive Chairman |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
347,327 |
1,934,064 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$3,433,554 |
D/D |
(80,554) |
101,369 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
58,778 |
181,923 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$2,073,098 |
D/D |
64,322 |
123,145 |
|
- |
|
| Young John D |
Group President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$7,296,903 |
D/D |
(171,349) |
366,757 |
|
- |
|
| Young John D |
Group President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
538,106 |
|
- |
|
| Young John D |
Group President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$4,975,474 |
D/D |
154,374 |
441,923 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$471,364 |
D/D |
(11,085) |
19,230 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,680 |
30,315 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$380,056 |
D/D |
11,792 |
23,635 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$1,047,729 |
D/D |
(24,635) |
105,125 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,017 |
129,760 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$829,246 |
D/D |
25,729 |
121,743 |
|
- |
|
| Lewis-Hall Freda C |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$3,794,983 |
D/D |
(89,126) |
375,244 |
|
- |
|
| Lewis-Hall Freda C |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
48,092 |
464,370 |
|
- |
|
| Lewis-Hall Freda C |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$2,625,939 |
D/D |
81,475 |
416,278 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2019-02-27 |
4 |
D |
$42.93 |
$3,167,075 |
D/D |
(73,773) |
332,488 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
406,261 |
|
- |
|
| Mackenzie Alexander R |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.93 |
$467,164 |
D/D |
(10,882) |
125,086 |
|
- |
|
| Mackenzie Alexander R |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,446 |
135,968 |
|
- |
|
| Johnson Rady A |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$1,491,915 |
D/D |
(35,020) |
68,497 |
|
- |
|
| Johnson Rady A |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,176 |
103,517 |
|
- |
|
1390 Records found
|
|
Page 13 of 56 |
|
|
0.44 (1.55%) 
